China, India Compulsory Licensing Laws Drive Branded Drugs Adjustment
This article was originally published in PharmAsia News
Executive Summary
With the two largest developing nations in South Asia, China and India, having adopted compulsory-licensing laws, makers of innovative drugs face a need to adjust their sources of materials, prices and distribution.